Total Funding
74
42
Total FundingSeries A raised
Growth Score
-9 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
65842
InterVene is a medical device company that treats severe venous disease in the legs.
Jeff Elkins: CEOPast Role: Veniti, President & CEO
Michi Garrison: VP, R&D and OperationsPast Role: Silk Road Medical, VP, Research and Development
About the Company
InterVene is a medical device company focused on innovating treatments for chronic venous disease, particularly deep vein valve failure. The company’s BlueLeaf™ Endovenous Valve Formation System offers a non-implantable solution to address severe venous conditions. InterVene aims to improve patient outcomes by providing minimally invasive therapies
for venous stasis ulcers and related symptoms.
